Edition:
United States

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

15.19USD
3:59pm EST
Change (% chg)

$1.34 (+9.68%)
Prev Close
$13.85
Open
$13.76
Day's High
$15.92
Day's Low
$13.76
Volume
5,853
Avg. Vol
--
52-wk High
$18.17
52-wk Low
$11.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.708
Jun '17 0.00 -1.488
FY 2016 Dec '16 0.00 -0.693
Sep '16 0.00 -1.187
Jun '16 0.00 -1.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.43 0.50 0.40 --
Earnings (per share)
Quarter Ending Mar-18 3 -0.48 -0.41 -0.52 --
Quarter Ending Jun-18 3 -0.59 -0.57 -0.63 --
Year Ending Dec-18 3 -2.63 -2.38 -2.90 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 50.97 35.76
P/E High - Last 5 Yrs. -- 41.22 46.66
P/E Low - Last 5 Yrs. -- 21.05 24.18
Beta -- 0.79 0.81
Price to Sales (TTM) -- 7.46 8.59
Price to Book (MRQ) -- 14.23 5.23
Price to Tangible Book (MRQ) 12.41 23.15 6.37
Price to Cash Flow (TTM) -- 23.88 26.13
% Owned Institutions 62.75 4.53 2.31

Dividends

  Company industry sector
Dividend Yield -- 0.94 1.50
Dividend Yield - 5 Year Avg -- 1.15 2.01
Dividend 5 Year Growth Rate -- 17.53 5.25
Payout Ratio(TTM) -- 59.55 44.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 14.31 9.62
Sales (TTM) vs TTM 1 Yr. Ago -- 10.95 7.31
Sales - 5 Yr. Growth Rate -- 8.94 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 40.38 74.17 18.60
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 19.66 11.47
Capital Spending - 5 Yr. Growth Rate -- 9.61 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.43 2.43
Current Ratio (MRQ) 7.02 3.20 3.39
LT Debt to Equity (MRQ) 47.61 28.40 11.95
Total Debt to Equity (MRQ) 47.61 32.37 15.32
Interest Coverage (TTM) -- 20.03 38.67

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.03 54.89
Gross Margin - 5 Yr. Avg. -- 57.59 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 23.20 10.03
Operating Margin (TTM) -- 18.58 2.96
Operating Margin - 5 Yr. Avg. -- 15.93 5.27
Pre-Tax Margin (TTM) -- 18.26 3.78
Pre-Tax Margin - 5 Yr. Avg. -- 16.14 5.53
Net Profit Margin (TTM) -- 13.89 0.26
Net Profit Margin - 5 Yr. Avg. -- 11.23 1.79
Effective Tax Rate (TTM) -- 22.97 22.06
Effective Tax Rate - 5 Yr. Avg. -- 29.15 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 29,208,061 824,372,705
Net Income/Employee (TTM) -- 3,675,107 96,444,553
Receivable Turnover (TTM) -- 4.88 5.41
Inventory Turnover (TTM) -- 3.04 3.49
Asset Turnover (TTM) -- 0.76 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.59 10.73
Return on Assets - 5 Yr. Avg. -- 8.93 12.02
Return on Investment (TTM) -- 14.13 13.59
Return on Investment - 5 Yr. Avg. -- 11.65 15.73
Return on Equity (TTM) -- 16.74 15.20
Return on Equity - 5 Yr. Avg. -- 14.06 16.95
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -81.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for scPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.76%
# of Holders: 26
Total Shares Held: 11,051,817
3 Mo. Net Change: 7,641,952
# New Positions: 25
# Closed Positions: 0
# Increased Positions: 25
# Reduced Positions: 0
# Net Buyers: 25
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.